Novartis breaks ground for RTP expansion

North Carolina Gov. Josh Stein joined state and local officials and life sciences partners to help Novartis break ground on its plans to expand its pharmaceutical manufacturing facilities in the Research Triangle.

Novartis’ expansion is part of a $771 million investment in Durham and Wake counties and will support more than 700 new jobs and expand the company’s capacity to produce medicines.

“North Carolina continues to lead in cutting-edge life sciences,” Stein said, at the ceremony last week. “Novartis’ decision to deepen its roots here speaks to the strength of our talent, our research universities, and our commitment to leading the nation in advanced pharmaceutical manufacturing. These investments bring in more good-paying jobs for North Carolinians and build a stronger, more resilient supply chain for patients across the country.” 

Novartis has operated in North Carolina for more than two decades, delivering gene therapies and other lifesaving treatments to patients around the world. This expansion includes new construction and renovations across multiple RTP sites, nearly doubling the company’s operational footprint to more than 700,000 square feet.

For details on Novartis’ expansion plans, see NCBiotech’s previous coverage.